A carregar...
RepSox Slows Decay of CD34(+) Acute Myeloid Leukemia Cells and Decreases T Cell Immunoglobulin Mucin-3 Expression
Despite initial response to therapy, most acute myeloid leukemia (AML) patients relapse. To eliminate relapse-causing leukemic stem/progenitor cells (LPCs), patient-specific immune therapies may be required. In vitro cellular engineering may require increasing the “stemness” or immunogenicity of tum...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4073822/ https://ncbi.nlm.nih.gov/pubmed/24855276 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2013-0193 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|